Press-release for stocks for sanofi for TAK

| 0.0% | O: 0.42% H: 0.0% C: 0.0%
SNY | News | $46.545 2.55% 2.3M

| 0.0% | O: 0.82% H: 0.0% C: 0.0%
MIRM | $23.63 0.26% 190K

| 0.0% | O: 1.42% H: 0.0% C: 0.0%
report million reach treatment market

Monoclonal Antibody (mABs) Therapeutics Market Worth $497.5 billion | MarketsandMarkets™
Published: 2024-03-15 (Crawled : 14:30) - prnewswire.com
TAK | News | $13.19 0.23% 740K

| -8.3% | O: 0.21% H: 0.97% C: 0.7%
NVS | $94.285 1.85% 1.6M

| -5.15% | O: 0.05% H: 0.14% C: -0.93%
JNJ | News | $147.895 1.48% 5.8M

| -9.85% | O: -1.58% H: 0.0% C: 0.0%
LLY | $727.48 -2.48% 2M

| -1.31% | O: -0.7% H: 0.73% C: -0.16%
ABBV | News | $165.97 0.8% 3.1M

| -8.4% | O: -0.07% H: 0.0% C: 0.0%
SNY | News | $46.545 2.55% 2.3M

| -6.03% | O: -0.02% H: 0.0% C: 0.0%
REGN | $893.67 -0.04% 230K

| -6.03% | O: -0.27% H: 1.26% C: 0.84%
AMGN | $267.41 1.77% 1.4M

| -2.43% | O: 0.2% H: 1.14% C: -1.18%
antibody therapeutics market

Non-Small Cell Lung Cancer (NSCLC) Market to Reach $29.95 Billion by 2028, Fueled by Advances in Therapy and Diagnostics
Published: 2024-02-22 (Crawled : 01:00) - prnewswire.com
GLAXF | $20.2 510

| -5.87% | O: 0.14% H: 0.0% C: -0.0%
SNYNF | News | $92.7 600K

| -3.13% | O: 0.26% H: 1.36% C: 1.36%
AZNCF | $138.24 800

| 6.54% | O: -0.85% H: 1.12% C: 0.43%
NVSEF | $93.6375 6.88% 82K

| -8.14% | O: 0.92% H: 0.0% C: 0.0%
UCBJY | $63.676 7.2K

| 25.87% | O: 1.46% H: 0.44% C: 0.44%
ALPMY | $9.47 520K

| -16.01% | O: -0.27% H: 0.0% C: -1.17%
TAK | News | $13.19 0.23% 740K

| -10.79% | O: -0.2% H: 0.14% C: -0.48%
NVS | $94.285 1.85% 1.6M

| -9.24% | O: -0.06% H: 0.46% C: 0.29%
GSK | $39.585 0.8% 1.1M

| -5.58% | O: -0.69% H: 1.42% C: 1.22%
LLY | $727.48 -2.48% 2M

| 0.65% | O: 2.37% H: 1.51% C: 0.79%
BMY | $48.89 1.22% 5.1M

| -5.13% | O: -0.65% H: 1.63% C: 1.48%
ABBV | News | $165.97 0.8% 3.1M

| -6.33% | O: -0.88% H: 1.46% C: 1.13%
SNY | News | $46.545 2.55% 2.3M

| -3.44% | O: 1.67% H: 0.0% C: 0.0%
AZN | $68.41 0.07% 2.9M

| 4.88% | O: -2.81% H: 2.08% C: 1.38%
AMGN | $267.41 1.77% 1.4M

| -6.54% | O: -0.35% H: 1.15% C: 0.96%
lung reach cancer cell diagnostics therapy market

Protein Inhibitors Global Market Report 2024 - A $125 Billion Market in 2028, Registering Compound Annual Growth of 9%
Published: 2024-02-14 (Crawled : 02:00) - prnewswire.com
LZAGF | $563.5 6

| 12.7% | O: 3.14% H: 1.92% C: 1.92%
GLAXF | $20.2 510

| -3.81% | O: -2.14% H: 0.0% C: -0.63%
SNYNF | News | $92.7 600K

| -0.29% | O: -2.71% H: 0.0% C: 0.0%
AZNCF | $138.24 800

Professional, Scientific, and T...

| 9.56% | O: 0.87% H: 0.21% C: -2.23%
LZAGY | $55.65 32K

| 15.41% | O: 4.07% H: 1.53% C: 1.45%
TMO | News | $543.895 0.44% 830K

| -1.04% | O: 0.56% H: 1.3% C: 1.22%
TAK | News | $13.19 0.23% 740K

| -8.3% | O: 0.42% H: 1.04% C: 0.97%
JNJ | News | $147.895 1.48% 5.8M

| -8.08% | O: -0.91% H: 0.0% C: 0.0%
GSK | $39.585 0.8% 1.1M

| -4.32% | O: 0.89% H: 0.41% C: 0.1%
LLY | $727.48 -2.48% 2M

| 1.05% | O: 0.38% H: 2.44% C: 1.54%
BAX | $39.47 -0.45% 1.3M

| 0.2% | O: 0.33% H: 0.63% C: -0.28%
ABBV | News | $165.97 0.8% 3.1M

| -5.33% | O: -0.73% H: 0.0% C: 0.0%
ABT | News | $106.76 1.42% 3.8M

| -5.49% | O: -0.83% H: 0.66% C: 0.38%
SNY | News | $46.545 2.55% 2.3M

| -1.43% | O: -1.1% H: 0.0% C: 0.0%
GLPG | $28.905 -0.02% 44K

| -25.19% | O: -1.72% H: 1.8% C: 1.59%
BIIB | $193.75 1.7% 1M

| -13.9% | O: 0.16% H: 0.43% C: -2.76%
AZN | $68.41 0.07% 2.9M

| 11.85% | O: 0.28% H: 0.93% C: 0.75%
AMGN | $267.41 1.77% 1.4M

| -8.79% | O: -0.21% H: 0.34% C: 0.07%
report global protein growth market

Checkpoint Inhibitors Market Forecast Reveals Impressive Growth With Focus on Novel Therapies and Regional Expansion
Published: 2024-02-12 (Crawled : 23:00) - prnewswire.com
GLAXF | $20.2 510

| -1.6% | O: 3.52% H: 0.0% C: -1.18%
AZNCF | $138.24 800

| 12.13% | O: 0.06% H: 2.34% C: 2.29%
ALPMY | $9.47 520K

| -13.68% | O: 0.37% H: 0.74% C: 0.28%
TAK | News | $13.19 0.23% 740K

| -8.11% | O: 0.14% H: 0.35% C: 0.07%
NVS | $94.285 1.85% 1.6M

| -7.41% | O: -0.34% H: 0.23% C: -1.13%
JNJ | News | $147.895 1.48% 5.8M

| -7.44% | O: 0.7% H: 0.0% C: 0.0%
GSK | $39.585 0.8% 1.1M

| -3.58% | O: 1.22% H: 0.07% C: -0.43%
LLY | $727.48 -2.48% 2M

| 1.83% | O: -0.96% H: 1.75% C: 1.75%
BMY | $48.89 1.22% 5.1M

| -2.91% | O: -0.18% H: 0.48% C: -1.91%
ABBV | News | $165.97 0.8% 3.1M

| -4.57% | O: 0.8% H: 0.0% C: 0.0%
ZLAB | News | $14.115 -0.74% 110K

| -25.59% | O: -1.15% H: 1.03% C: -1.5%
VRTX | News | $395.0 0.39% 550K

| -5.63% | O: -0.28% H: 0.49% C: -0.32%
SNY | News | $46.545 2.55% 2.3M

| -1.49% | O: -0.06% H: 0.0% C: 0.0%
IPHA | $2.35 3.8K

| -8.91% | O: -3.1% H: 1.2% C: -0.8%
INCY | $52.07 -1.42% 800K

| -8.68% | O: 3.8% H: 1.1% C: -1.17%
BIIB | $193.75 1.7% 1M

| -20.26% | O: -3.72% H: 0.58% C: -3.82%
AZN | $68.41 0.07% 2.9M

| 11.16% | O: -0.26% H: 0.73% C: -0.36%
ARGX | $359.51 0.31% 280K

| -5.61% | O: -2.3% H: 1.65% C: 0.83%
AMGN | $267.41 1.77% 1.4M

| -10.02% | O: 0.06% H: 0.31% C: -1.4%
expansion growth market

Blood Cancer Drugs Market Report 2023: Reveals Striking Growth Prospects with a Surge in R&D Activities - Long-term Forecasts to 2028 and 2033
Published: 2024-02-06 (Crawled : 00:00) - prnewswire.com
ALPMF | $9.17 16K

| -13.72% | O: -1.53% H: 0.0% C: 0.0%
AZNCF | $138.24 800

| 1.09% | O: -0.37% H: 0.0% C: 0.0%
NVSEF | $93.6375 6.88% 82K

| -8.98% | O: 0.41% H: 0.0% C: 0.0%
UCBJY | $63.676 7.2K

| 37.02% | O: 1.71% H: 1.28% C: 0.94%
ALPMY | $9.47 520K

| -14.23% | O: 0.28% H: 0.18% C: 0.0%
TAK | News | $13.19 0.23% 740K

| -7.13% | O: 0.07% H: 0.42% C: 0.07%
NVS | $94.285 1.85% 1.6M

| -10.28% | O: 0.09% H: 0.39% C: -0.36%
JNJ | News | $147.895 1.48% 5.8M

| -6.93% | O: 1.47% H: 0.0% C: 0.0%
LLY | $727.48 -2.48% 2M

| 6.49% | O: 0.76% H: 4.31% C: 2.11%
BMY | $48.89 1.22% 5.1M

| -1.95% | O: -0.14% H: 0.35% C: -1.12%
ABBV | News | $165.97 0.8% 3.1M

| -3.43% | O: 1.48% H: 0.0% C: 0.0%
VRTX | News | $395.0 0.39% 550K

| -5.09% | O: 0.15% H: 2.4% C: 0.56%
SNY | News | $46.545 2.55% 2.3M

| -2.19% | O: 1.33% H: 0.0% C: 0.0%
JAZZ | $110.6 1.22% 210K

| -14.12% | O: -0.02% H: 0.0% C: -1.4%
AZN | $68.41 0.07% 2.9M

| 1.83% | O: -0.4% H: 0.19% C: -0.33%
AMGN | $267.41 1.77% 1.4M

| -16.18% | O: -0.18% H: 0.0% C: -6.22%
report cancer blood growth market

Red Biotechnology Market to Reach $1,513.22 Billion, Globally, by 2030 at 10.7% CAGR: Coherent Market Insights
Published: 2023-12-08 (Crawled : 08:00) - prnewswire.com
ALPMF | $9.17 16K

| -22.28% | O: -2.79% H: 0.62% C: 0.62%
SNYNF | News | $92.7 600K

| 2.34% | O: 2.06% H: 0.82% C: 0.82%
NVSEF | $93.6375 6.88% 82K

| -3.34% | O: -1.29% H: 0.4% C: 0.4%
ALPMY | $9.47 520K

| -23.82% | O: -2.2% H: 0.0% C: -0.27%
TAK | News | $13.19 0.23% 740K

| -6.61% | O: -0.64% H: 0.5% C: 0.5%
NVO | $122.69 -0.05% 3.8M

| 28.63% | O: -0.42% H: 0.67% C: 0.25%
NVS | $94.285 1.85% 1.6M

| -2.97% | O: 0.19% H: 0.35% C: 0.2%
JNJ | News | $147.895 1.48% 5.8M

| -7.07% | O: -0.18% H: 0.0% C: 0.0%
LLY | $727.48 -2.48% 2M

| 27.99% | O: 0.43% H: 0.0% C: 0.0%
BMY | $48.89 1.22% 5.1M

| -3.71% | O: 0.2% H: 0.55% C: 0.1%
ABBV | News | $165.97 0.8% 3.1M

| 11.75% | O: 0.3% H: 0.0% C: 0.0%
SNY | News | $46.545 2.55% 2.3M

| -0.46% | O: 1.07% H: 0.0% C: 0.0%
GILD | News | $66.45 0.44% 4.3M

| -14.29% | O: 0.08% H: 1.45% C: 1.17%
AMGN | $267.41 1.77% 1.4M

| -2.35% | O: -0.05% H: 0.3% C: -0.76%
reach market

Insomnia Therapeutics Market to grow by USD 1 billion from 2022-2027 | North America to account for 60% of market growth - Technavio
Published: 2023-11-27 (Crawled : 22:00) - prnewswire.com
SNYNF | News | $92.7 600K

| -2.28% | O: -1.89% H: 0.02% C: 0.02%
ALPMY | $9.47 520K

| -23.82% | O: -4.49% H: 6.23% C: 3.42%
VTRS | $11.21 0.81% 2.4M

| 19.06% | O: -0.21% H: 0.21% C: -1.93%
TAK | News | $13.19 0.23% 740K

| -6.54% | O: -0.07% H: 0.28% C: 0.21%
ABT | News | $106.76 1.42% 3.8M

| 3.59% | O: -0.24% H: 0.03% C: -0.39%
VNDA | $5.17 4.02% 1.8M

| 47.19% | O: 2.81% H: 0.0% C: -3.01%
SNY | News | $46.545 2.55% 2.3M

| -4.49% | O: -1.41% H: 0.87% C: 0.0%
america therapeutics growth market

COVID-19 Challenges Drive the Need for Resilient Supply Chains and Digital Healthcare in the Anti-Epileptic Drugs Market, Shaping the Post-Pandemic Landscape
Published: 2023-11-06 (Crawled : 19:00) - prnewswire.com
GLAXF | $20.2 510

| 17.51% | O: 0.41% H: 0.0% C: 0.0%
VTRS | $11.21 0.81% 2.4M

| 20.74% | O: 0.11% H: 0.33% C: -0.98%
TEVA | $12.905 0.98% 5.9M

| 45.64% | O: 0.22% H: 1.49% C: -0.33%
TAK | News | $13.19 0.23% 740K

| -4.08% | O: 0.44% H: 0.22% C: 0.07%
NVS | $94.285 1.85% 1.6M

| -0.4% | O: 0.24% H: 0.18% C: 0.16%
JNJ | News | $147.895 1.48% 5.8M

| -4.43% | O: 0.18% H: 0.0% C: 0.0%
GSK | $39.585 0.8% 1.1M

| 13.83% | O: 0.55% H: 0.3% C: 0.0%
ABT | News | $106.76 1.42% 3.8M

| 11.32% | O: -0.42% H: 0.0% C: 0.0%
SNY | News | $46.545 2.55% 2.3M

| -0.36% | O: -1.32% H: 0.0% C: 0.0%
covid-19

Global Bleeding Disorders Treatment Market Surpasses $14 Billion in 2022, Expected to Reach $20.3 Billion by 2028
Published: 2023-10-25 (Crawled : 22:00) - prnewswire.com
TAK | News | $13.19 0.23% 740K

| -9.31% | O: -4.69% H: 0.69% C: -3.18%
NVO | $122.69 -0.05% 3.8M

| 27.81% | O: -1.47% H: 0.22% C: -0.83%
JNJ | News | $147.895 1.48% 5.8M

| -4.37% | O: 0.1% H: 0.0% C: 0.0%
SNY | News | $46.545 2.55% 2.3M

| -14.28% | O: 0.09% H: 0.0% C: 0.0%
bleeding expected reach disorders treatment global market

Global Bleeding Disorders Market Set to Surge, Expected to Reach $25.97 Billion by 2032 with a 6.6% CAGR
Published: 2023-09-27 (Crawled : 02:00) - prnewswire.com
SNYNF | News | $92.7 600K

| -14.76% | O: -0.69% H: 0.0% C: 0.0%
TAK | News | $13.19 0.23% 740K

| -17.61% | O: 0.56% H: 0.06% C: -0.62%
NVO | $122.69 -0.05% 3.8M

| 35.67% | O: -0.51% H: 0.62% C: 0.42%
SNY | News | $46.545 2.55% 2.3M

| -16.06% | O: -0.5% H: 0.0% C: 0.0%
GRFS | News | $6.29 -3.82% 740K

| -28.6% | O: -0.22% H: 1.09% C: -0.55%
bleeding expected reach disorders global set market

Global Antibodies Market Set to Soar, Projected to Reach $524.8 Billion by 2030 with a CAGR of 12.9%
Published: 2023-09-12 (Crawled : 23:00) - prnewswire.com
SNYNF | News | $92.7 600K

| -15.3% | O: -1.8% H: 0.0% C: 0.0%
TAK | News | $13.19 0.23% 740K

| -16.82% | O: 0.63% H: 0.5% C: 0.31%
JNJ | News | $147.895 1.48% 5.8M

| -10.56% | O: 1.05% H: 0.73% C: 0.14%
BMY | $48.89 1.22% 5.1M

| -19.82% | O: 0.02% H: 0.55% C: -1.0%
ABBV | News | $165.97 0.8% 3.1M

| 10.65% | O: 0.05% H: 0.0% C: 0.0%
RARE F | $41.575 -4.16% 370K

| 6.52% | O: -0.02% H: 1.4% C: -1.07%
SNY | News | $46.545 2.55% 2.3M

| -16.91% | O: -0.99% H: 0.0% C: 0.0%
MOR | $17.94 -0.61% 110K

| 123.39% | O: 0.0% H: 0.63% C: -1.98%
IOVA M | $11.3 -3.58% 2.8M

| 97.99% | O: -0.34% H: 0.51% C: -8.5%
INCY | $52.07 -1.42% 800K

| -17.76% | O: 0.0% H: 0.53% C: -1.76%
BIIB | $193.75 1.7% 1M

| -24.49% | O: 0.07% H: 0.53% C: -1.05%
AMGN | $267.41 1.77% 1.4M

| 1.78% | O: -0.37% H: 0.34% C: -0.81%
reach global set market

Global Hemophilia Research Analysis Report 2023: A $21.07 Billion Market by 2030 - Approval of Gene Therapies and Monoclonal Antibodies Fueling Growth
Published: 2023-08-16 (Crawled : 01:00) - prnewswire.com
TAK | News | $13.19 0.23% 740K

| -13.43% | O: -0.26% H: 0.26% C: -0.46%
PFE A | $25.91 2.05% 22M

| -28.17% | O: -0.71% H: 1.45% C: 0.97%
NVO | $122.69 -0.05% 3.8M

| 34.55% | O: -0.3% H: 1.35% C: 0.05%
SNY | News | $46.545 2.55% 2.3M

| -14.49% | O: -1.33% H: 0.0% C: 0.0%
report approval research global growth market

Global CNS Therapeutics Strategic Business Report 2023: Burgeoning Global Aging Populace, Longer Life Expectancy to Drive CNS Demand
Published: 2023-06-30 (Crawled : 23:00) - prnewswire.com
ALKS | $23.735 -0.11% 620K

| Email alert Add to watchlist
JNJ | News | $147.895 1.48% 5.8M

| Email alert Add to watchlist
NBIX M | $130.31 -1.68% 260K

| Email alert Add to watchlist
SNYNF | News | $92.7 600K

| Email alert Add to watchlist
UCBJY | $63.676 7.2K

| Email alert Add to watchlist
UCBJF | $126.05 100

| Email alert Add to watchlist
AZNCF | $138.24 800

| Email alert Add to watchlist
PFE A | $25.91 2.05% 22M

| Email alert Add to watchlist
TAK | News | $13.19 0.23% 740K

| Email alert Add to watchlist
NVSEF | $93.6375 6.88% 82K

| Email alert Add to watchlist
NVS | $94.285 1.85% 1.6M

| Email alert Add to watchlist
BMY | $48.89 1.22% 5.1M

| Email alert Add to watchlist
AZN | $68.41 0.07% 2.9M

| Email alert Add to watchlist
TEVJF | $12.37 -24.22% 380

| Email alert Add to watchlist
LLY | $727.48 -2.48% 2M

| Email alert Add to watchlist
SNY | News | $46.545 2.55% 2.3M

| Email alert Add to watchlist
ABBV | News | $165.97 0.8% 3.1M

| Email alert Add to watchlist
report business life global therapeutics

Global Constipation Treatment Markets to 2030: A $27.5 Billion Industry Opportunity with Laxatives Accounting for $12.3 Billion
Published: 2023-06-19 (Crawled : 17:00) - prnewswire.com
MNKPF | $17.25

| Email alert Add to watchlist
BHC | $8.63 0.35% 2.1M

| Email alert Add to watchlist
MNKKQ | $0.02

| Email alert Add to watchlist
TAK | News | $13.19 0.23% 740K

| Email alert Add to watchlist
ALBO | $44.15 -0.23% 0.39% 1.2M

| Email alert Add to watchlist
SNYNF | News | $92.7 600K

| Email alert Add to watchlist
MNK | $0.3402 -0.06% 540K

| Email alert Add to watchlist
SNY | News | $46.545 2.55% 2.3M

| Email alert Add to watchlist
treatment global

Peptide Therapeutics Global Market Report 2023: Increase in the Prevalence of Chronic Diseases Drives Growth
Published: 2023-06-01 (Crawled : 22:00) - prnewswire.com
SNYNF | News | $92.7 600K

| -8.59% | O: -0.56% H: 0.0% C: 0.0%
AZNCF | $138.24 800

| -8.39% | O: -0.74% H: 1.4% C: 0.35%
NVSEF | $93.6375 6.88% 82K

| 15.61% | O: 0.99% H: 0.0% C: 0.0%
TAK | News | $13.19 0.23% 740K

| -17.24% | O: 1.32% H: 0.31% C: 0.12%
PFE A | $25.91 2.05% 22M

| -33.14% | O: 0.6% H: 1.07% C: 0.29%
NVO | $122.69 -0.05% 3.8M

| -21.17% | O: -1.84% H: 1.62% C: 1.33%
NVS | $94.285 1.85% 1.6M

| -4.15% | O: 1.03% H: 0.84% C: 0.82%
BMY | $48.89 1.22% 5.1M

| -25.32% | O: 0.37% H: 1.34% C: 1.14%
SNY | News | $46.545 2.55% 2.3M

| -9.41% | O: 1.05% H: 0.0% C: 0.0%
AZN | $68.41 0.07% 2.9M

| -6.28% | O: 0.11% H: 0.69% C: -0.45%
report global therapeutics growth market

Targeted Therapy Global Market Report 2023: Increasing Prevalence of Cancer Drives Growth
Published: 2023-05-15 (Crawled : 17:00) - prnewswire.com
GNMSF | $290.38 220

| -33.14% | O: 0.24% H: 0.66% C: 0.66%
NVSEF | $93.6375 6.88% 82K

| 7.89% | O: -1.1% H: 0.0% C: 0.0%
TAK | News | $13.19 0.23% 740K

| -19.72% | O: 0.61% H: 0.3% C: 0.24%
NVS | $94.285 1.85% 1.6M

| -9.75% | O: 0.2% H: 0.13% C: -0.22%
GSK | $39.585 0.8% 1.1M

| 8.4% | O: 0.27% H: 0.6% C: 0.41%
SNY | News | $46.545 2.55% 2.3M

| -15.86% | O: 0.38% H: 0.0% C: 0.0%
GMAB | $28.68 1.23% 150K

| -31.57% | O: 0.38% H: 0.91% C: 0.69%
AMGN | $267.41 1.77% 1.4M

| 13.73% | O: 0.14% H: 0.28% C: 0.11%
report cancer global therapy growth market

Global Acute Repetitive Seizures Market to Showcase Promising Growth says Brandessence Market Research
Published: 2023-05-15 (Crawled : 10:00) - prnewswire.com
UCBJY | $63.676 7.2K

| 38.83% | O: 1.79% H: 0.18% C: -0.06%
TAK | News | $13.19 0.23% 740K

| -19.72% | O: 0.61% H: 0.3% C: 0.24%
JNJ | News | $147.895 1.48% 5.8M

| -9.85% | O: 0.01% H: 0.14% C: -0.78%
LLY | $727.48 -2.48% 2M

| 72.82% | O: 0.22% H: 0.14% C: -0.2%
ABBV | News | $165.97 0.8% 3.1M

| 12.24% | O: 0.35% H: 0.83% C: -0.73%
VRTX | News | $395.0 0.39% 550K

| 13.69% | O: 0.17% H: 1.07% C: 0.19%
SNY | News | $46.545 2.55% 2.3M

| -15.86% | O: 0.38% H: 0.0% C: 0.0%
GILD | News | $66.45 0.44% 4.3M

| -14.42% | O: -0.13% H: 0.42% C: 0.4%
research global growth market

Global Gaucher's Disease Treatment Market Research Report 2023: Emerging Therapies, Clinical Trials, Treatments, Current Scenario Evaluation, Patient Profile
Published: 2023-05-10 (Crawled : 18:00) - prnewswire.com
NVSEF | $93.6375 6.88% 82K

| 8.88% | O: 0.92% H: 0.0% C: 0.0%
TAK | News | $13.19 0.23% 740K

| -22.56% | O: -1.83% H: 0.12% C: -3.06%
NVS | $94.285 1.85% 1.6M

| -10.18% | O: -0.4% H: 0.34% C: 0.19%
JNJ | News | $147.895 1.48% 5.8M

| -10.33% | O: 0.11% H: 0.22% C: -0.52%
ABT | News | $106.76 1.42% 3.8M

| -3.88% | O: -0.57% H: 0.37% C: -0.01%
SNY | News | $46.545 2.55% 2.3M

| -15.88% | O: -0.28% H: 0.0% C: 0.0%
disease report treatment research global market

Global Depression Treatment Market to 2030: Rising Prevalence of Psychiatric Diseases and Development of Innovative Medications for Treatment-resistant Depression Drives Growth
Published: 2023-04-04 (Crawled : 02:00) - prnewswire.com
TAK | News | $13.19 0.23% 740K

| -20.4% | O: -0.12% H: 1.55% C: 1.03%
LLY | $727.48 -2.48% 2M

| 114.05% | O: 0.38% H: 1.97% C: 0.72%
BMY | $48.89 1.22% 5.1M

| -30.69% | O: 0.13% H: 0.0% C: -1.25%
SNY | News | $46.545 2.55% 2.3M

| -16.36% | O: -0.1% H: 0.0% C: 0.0%
depression treatment global growth market

← Previous
1
2
3
Next →

Gainers vs Losers

70%

30%

Top 10 Gainers

AGBA | News | $1.305 226.25% 130M

Finance

EGOX | $0.0503 39.72% 320M

RWOD | $10.52 31.56% 5.9M

ZCMD | $1.905 31.38% 30M

Commercial Services

MRDB 4 | $0.536 27.65% 2M

BSFC | $0.0822 27.64% 75M

TPET | $0.4121 25.68% 45M

NVFY | $2.65 25.59% 33M

Consumer Durables

INDO | $5.1 25.0% 15M

Energy Minerals

CHRO | $1.53 24.9% 100K